Back to RecallTracker
Health Canada Health products

Archived - Anti-TNFa Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab) - Advisories, Warnings and Recalls for the Public

Issued January 18, 2006